Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France.
PLoS One
; 15(1): e0225301, 2020.
Article
in En
| MEDLINE
| ID: mdl-31978044
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Atrial Fibrillation
/
Vitamin K
/
Stroke
/
Rivaroxaban
Type of study:
Health_economic_evaluation
/
Prognostic_studies
/
Systematic_reviews
Aspects:
Patient_preference
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
PLoS One
Journal subject:
CIENCIA
/
MEDICINA
Year:
2020
Document type:
Article
Affiliation country:
Reino Unido
Country of publication:
Estados Unidos